Gelonghui November 25th｜Medikai (688079.SH) stated on the investor interaction platform that since its listing, the company has been committed to enriching and improving its business structure. In addition to the existing optical products, it has focused on investing in areas such as semiconductor acousto-optics, semiconductor micro-nano circuits, semiconductor packaging and testing, and nano-optics. Currently, a complete set of acoustic layer solutions for ultrasonic fingerprint chip, a complete set of optical layer solutions for ambient light chip products, a complete set of optical layer solutions for CIS image sensors, and the wafer manufacturing and testing of RF chip SAW products have gradually realized mass production. In addition, RF chip BAW projects, multi-channel chromatographic chip optical layer products, and other products are in development testing and have completed the entire process of production. The company is also working on share repurchases, stock-based incentives, and other related tasks.